Page last updated: 2024-11-07

em 139

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

EM 139: EM-170 is the (17'alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131427
CHEMBL ID272049
MeSH IDM0177593

Synonyms (11)

Synonym
em-170
em 170
n-n-butyl-n-methyl-11-(16'alpha-chloro-3',17'beta-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl)undecanamide
estra-1,3,5(10)-triene-7-undecanamide, n-butyl-16-chloro-3,17-dihydroxy-n-methyl-, (7alpha,16alpha,17beta)-
em-139
131811-54-6
em 139
CHEMBL272049
n-butyl-11-[(7r,8r,9s,13s,14s,16r,17r)-16-chloro-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-7-yl]-n-methylundecanamide
n-butyl-11-[16-chloro-3,17-dihydroxyestra-1(10),2,4-trien-7-yl]-n-methylundecanamide
DTXSID30927357
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID115224Inhibition of estradiol-induced uterine weight gain in ovariectomized BALB/c mice at 20 ug dose twice daily1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Synthesis and biological activity of new halo-steroidal antiestrogens.
AID320281Reversal of estrogen-induced proliferation in estrogen-sensitive human MCF7 cells at 0.5 uM after 8 days relative to control2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
AID69543Relative binding affinity for estrogen receptor from immature rat uterus1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Synthesis and biological activity of new halo-steroidal antiestrogens.
AID115226Inhibition of estradiol-induced uterine weight gain in ovariectomized BALB/c mice at 3 ug dose twice daily1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Synthesis and biological activity of new halo-steroidal antiestrogens.
AID417698Estrogenic activity in human ZR-75-1 cells expressing estrogen receptor assessed as estrogen-induced cell proliferation at 1 uM after 9 days relative to estrogen2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
AID417701Antiestrogenic activity in human ZR-75-1 cells expressing estrogen receptor assessed as inhibition of estrogen-induced cell proliferation at 0.1 nM after 9 days relative to estrogen2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
AID417697Estrogenic activity in human ZR-75-1 cells expressing estrogen receptor assessed as estrogen-induced cell proliferation at 0.03 uM after 9 days relative to estrogen2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (81.82)18.2507
2000's2 (18.18)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.99 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index17.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]